Company intelligence / Profile preview

Vipergen

Copenhagen Ø, Capital Region, Denmarkvipergen.com ↗

Ownership: Private
Development stage: Commercial

Overview

Vipergen offers advanced small molecule drug discovery services using proprietary DNA Encoded Library technologies. Their platforms enable rapid identification of high-value hits/leads for even challenging targets, including those considered "undruggable." They do not have their own clinical pipeline but support partners in early-stage discovery.

Therapeutic areas: Oncology
Modalities: Small moleculeMolecular glue therapyPeptides
Industry: Drug Discovery Services

Partnerships

PhoreMost (multi-target drug discovery partnership focused on oncology)Top 5 pharma companies in USA, EU, Japan (between 2015–2024)

Beyond the preview

Go deeper on Vipergen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vipergen.

Explore the full profile